Trump Administration gives problems with the Major Covid vaccine -update

The Trump administration has introduced an important change in politics that limits routine access to annual COVID 19 vaccinations for healthy children and younger adults.

On Tuesday, the new framework, which was published in the New England Journal of Medicine, terminated the intention of the Food and Drug Administration (FDA) to limit the optimized vaccine access for adults aged 65 and over and younger people with underlying medical illnesses, which increase their risk of serious COVID-19.

Why is it important

This marks a shift in previous guidelines that encouraged annual covid recordings for almost all age groups.

While some celebrated the changes in the recommendations, influencer Diana Atieh from America was again disappointed by the decision because the vaccine is still recommended for other groups.

“It is really unfortunate to see Newsweek on Tuesday.

What to know?

The FDA commissioner Dr. Marty Makary and the head of the vaccine, Dr. Vinay Prasad, wrote the framework that the manufacturers of vaccines asks to carry out large, monthly clinical studies for new COVID-19 vaccine updates if they are intended for use in healthy, risk-like population groups.

According to the new instructions, an estimated 100 to 200 million people could be available annual shots, although those outside the categories could have a limited access. For them, the availability of the autumn booster could depend on individual providers or insurance protection.

The political shift takes place under the growing examination of the Covid 19 vaccine policy and precedes the first meeting of the FDA outdoor Vana as part of the Trump management. It also reflects the FDA decision in the past week to approve Novavax's covid vaccine, but with strict limits for who can get it -restrictions that, according to Trump, have overwritten the recommendation of FDA scientists for broader access.

Makary and Prasad criticized the previous “Unity Fits-All” model for Covid vaccination and found that the USA was “the most aggressive” among the industrialized countries when he was recommended. They questioned the benefits of additional doses for healthy people with previous infections and previous vaccinations.

The decision of the FDA also raises procedural questions. Experts find that the publication of new guidelines in a medical journal could violate federal standards before he undergoes the design and procedural process in the traditional process.

There is also the risk of driving the role of centers for the control and prevention of diseases (CDC), whose advisory committee will soon discuss group -specific vaccine recommendations.

Dr. Paul Offit, a vaccine expert in the children's hospital in Philadelphia, found that studies have shown that booster recordings reduce slight and moderate diseases for up to six months, even in healthy people, but the FDA seems to ensure that access has to be narrowed prematurely.

What people say

FDA official wrote: “We just don't know whether a healthy 52-year-old woman with a normal BMI who had Covid-19 three times and received six previous doses will benefit from the seventh dose.”

Asked Offit in comments on the Associated Press: “Will the pharmacist determine whether you are in a high -risk group?

The representative of Georgia, Marjorie Taylor Greene, told Newsweek: “I am enthusiastic about the new FDA guidelines for Covid vaccines! Nobody should have ever been forced to make an unproven and experimental shot. It turned out to be fatal with miscarriages and myocarditis after the American people had been forced to shot the Covid.

“Many thanks to the secretary Kennedy that she has rightly updated the guidance of the FDA. Big Pharma has earned enough money from the government's recommendations. It is time for the American people to have health freedom again.”

Atieh told Newsweek: “While I still have great hopes [Health and Human Services Secretary Robert F. Kennedy, Jr.] The system that emphasizes risks with vaccines in connection with vaccines.

“It is very important that the FDA also shows the risks with a medical procedure as vaccinations, and here they did not do that – which shows how little they take care of the consumer's declaration of consent.”

What's next

The framework indicates that future vaccines for healthy people require placebo -controlled studies, in particular the effects of the shot on serious illnesses, hospital stays and deaths.

This article contains reporting by the Associated Press.

Update: 20.05.25, 2:43 p.m. ET: This article has been updated with additional information and comments.

Update: 20.05.25, 2:43 p.m. ET: This article has been updated with additional information and comments.

Update: 20.05.25, 19:54 PM ET: This article has been updated with additional information and comments.